This new edition of a book first published in 1995, presents an accessible and up-to-date overview of Alzheimer's disease, with an emphasis on research into the molecular mechanisms of neuronal degeneration. Leading international experts have provided in-depth reviews of their areas of expertise, including coverage of the key molecules known to be involved, such as APP, tau, apolipoprotein E and the presenilins. Other areas covered include neuropathology, genetics, neurochemical pathology, inflammation, diagnosis, models of the disease and opportunities for treatment, employing both current and emerging drug therapies. The book will provide a readable introduction for those new to the subject, as well as covering a wide range of specialist topics for the more experienced researcher and those interested in the overlap with other related specialist areas. Also included are appendices detailing gene and protein information on APP, tau, the presenilins, apolipoprotein E and the newly cloned therapeutic target, BACE.
Rezensionen / Stimmen
I have no doubt that this book has easily achieved its aims ... of providing an accessible overview and a readable introduction to Alzheimer's disease ... I will recommend it most enthusiastically to my students and colleagues alike. Brain This book will appeal to the broad readership that it is intended for including researchers and clinicians. International Journal of Geriatric Psychiatry, 17
Auflage
Sprache
Verlagsort
Zielgruppe
Editions-Typ
Illustrationen
fig., num. halftones, 8 farbige Bildtafeln
Gewicht
ISBN-13
978-0-19-852459-5 (9780198524595)
Copyright in bibliographic data and cover images is held by Nielsen Book Services Limited or by the publishers or by their respective licensors: all rights reserved.
Schweitzer Klassifikation
1. Alzheimer's Disease: past, present and future themes; 2. The neuropathology of Alzheimer's Disease; 3. Molecular genetics of Alzheimer's Disease; 4. The biology and molecular neuropathology of beta-amyloid protein; 5. The molecular basis of tau protein pathology in Alzheimer's Disease and related neurodegenerative dementias; 6. Apolipoprotein E as a risk factor for Alzheimer's Disease; 7. The presenilin genes; 8. Transgenic models of Alzheimer's Disease neuropathology; 9. Cellular targets of amyloid beta peptide: potential roles in neuronal cell stress and toxicity; 10. Reflections on Alzheimer's Disease as a specific neurotransmitter disorder; 11. Clinical assessment of Alzheimer's Disease; 12. Molecular and biological markers for the diagnosis and monitoring of the progression of Alzheimer's Disease; 13. Alzheimer's Disease and neuroimaging; 14. Current pharmacological approaches to treating Alzheimer's Disease; 15. Current perspectives, future directions